Open App →
Back to News Feed
PR Newswire July 30, 2026 neutral

Ember LifeSciences and Alfresa Corporation Enter into Capital and Business Alliance to Improve the Quality of the Pharmaceutical Cold Chain in Japan

AI / LLM
<p>Ember offers Japanese market pharmaceutical transportation solution integrating temperature control, visualization of transportation status and traceability LOS ANGELES, July 29, 2026 /PRNewswire/ -- Ember LifeSciences, Inc. ("Ember"), an award-winning provider of advanced pharmaceutical...</p>
Read original article ↗